Astellas Venture Capital

Overview

Astellas Venture Capital is the corporate venture capital arm of Astellas Pharma Inc., a global pharmaceutical company headquartered in Japan. The firm specializes in investing in emerging biotechnology companies, aiming to support the growth of innovative firms in the biotech sector. Astellas Venture Capital manages multiple funds, including Astellas Venture Fund I L.P., and leverages Astellas Pharma's extensive experience and network in the biotechnology field to facilitate the development of its portfolio companies. The firm's investment strategy encompasses various stages of company development, from seed funding to buyouts and acquisitions. Astellas Venture Capital seeks to identify companies with proprietary technologies and provides not only financial support but also access to Astellas Pharma's scientific and technical expertise, depth of drug development and marketing knowledge, and long-term business perspective. This comprehensive support aims to give entrepreneurs and investors the best chance for rapid growth and success. By consolidating the venture investment activities of former Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd., Astellas Venture Capital continues to invest in and support the growth of promising emerging biotechnology companies, contributing to the advancement of the global biotech industry.

Investment Focus

• Companies with proprietary biotechnology technologies
• Potential for rapid growth and success
• Alignment with Astellas Pharma's strategic interests